ScholarIQanswers from OpenAlex & ORCID
David D. Stenehjem
ResearcherPublications, citations & collaboration network
David D. Stenehjem is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David D. Stenehjem have?
ScholarIQindexed works
David D. Stenehjem has 244 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David D. Stenehjem have?
ScholarIQcitation count
David D. Stenehjem has 2,848 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David D. Stenehjem?
ScholarIQh-index
David D. Stenehjem has an h-index of 23 in OpenAlex.
What is the i10-index of David D. Stenehjem?
ScholarIQi10-index
David D. Stenehjem has an i10-index of 47 in OpenAlex.
What is the ORCID of David D. Stenehjem?
ScholarIQorcid
The ORCID for David D. Stenehjem is on the source record.
What is the OpenAlex record for David D. Stenehjem?
ScholarIQopenalex
The OpenAlex for David D. Stenehjem is on the source record.
What are the most-cited papers on David D. Stenehjem?
ScholarIQmost cited works
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman, Marc Carrier, Cihan Ay, Marcello Di Nisio, Lisa K. Hicks, Alok A. Khorana, Andrew D. Leavitt, Agnes Lee, Fergus Macbeth, Rebecca L. Morgan, Simon Noble, Elizabeth A. Sexton, David D. Stenehjem, Wojtek Wiercioch, Lara A Kahale, Pablo Alonso‐Coello
Diagnosis and treatment of cancer‐related anemia
Jeffrey A. Gilreath, David D. Stenehjem, George M. Rodgers
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer
David D. Stenehjem, Dao Tran, Michael Nkrumah, Shilpa Gupta
Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer
David Waterhouse, Jenny Lam, Keith A. Betts, Lei Yin, Sophie Gao, Yong Yuan, John Hartman, Sumati Rao, Solomon J. Lubinga, David D. Stenehjem
Circulating immune cell phenotype dynamics reflect the strength of tumor–immune cell interactions in patients during immunotherapy
Jason I. Griffiths, Pierre Wallet, Lance Pflieger, David D. Stenehjem, Xuan Liu, Patrick A. Cosgrove, Neena A. Leggett, Jasmine A. McQuerry, Gajendra Shrestha, Maura Rossetti, Gemalene Sunga, Philip J. Moos, Frederick R. Adler, Jeffrey T. Chang, Sunil Sharma, Andrea H. Bild